L. V. Chichanovskaya

Neurological disorders in patients with long COVID syndrome and cell therapy methods for their correction a literature review

M. Rykov, G. Mentkevich, I. Dolgopolov, 2021, Sechenov Medical Journal.

[Efficacy, tolerability and safety of the treatment with teberif: the results of a 2-year randomized clinical trial of treatment naïve patients with remitting multiple sclerosis, who have not received DMT, after switching from other interferon β-1a].

M. Zakharova, A. Boyko, S. Prokopenko, 2019, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

A Comparative Placebo-Controlled Clinical Trial of the Efficacy and Safety of Interferon β-1a Formulations for S.C. Administration in Patients with Remitting Multiple Sclerosis: First-Year Results

M. Zakharova, S. Prokopenko, F. Khabirov, 2018, Neuroscience and Behavioral Physiology.

[A comparative placebo-controlled clinical study on the efficacy and safety of interferon beta-1a for subcutaneous injections in patients with remitting multiple sclerosis: results of the first year of observations].

M. Zakharova, A. Boyko, S. Prokopenko, 2017, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

Efficacy of Complex Antioxidant Energy Correction of Different Durations in the Treatment of Cerebral Infarction (results of a multicenter randomized study)

V. Stupin, E. Silina, A. Kovalenko, 2017, Neuroscience and Behavioral Physiology.

[Clinical and morphologic efficacy of a complex antioxidant and energy correction therapy of different duration in brain infarction: results of a multicenter randomized trial].

M. Salnikov, A. Kovalenko, K. Golikov, 2015, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[Efficacy of antioxidant energocorreсtion in brain infarction (results of a multicenter randomized trial)].

V. Stupin, E. Silina, A. Kovalenko, 2014, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.